Arcutis Vertex: Which Pharmaceutical Stock Is Better in 2026
In 2026, investors face a classic showdown: a rapid-growth dermatology
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,329 articlesIn 2026, investors face a classic showdown: a rapid-growth dermatology
As the VIX climbs and markets wobble, a small group of overlooked stocks has kept delivering. Here are the five names...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
P&G leads with broad-based growth and new investments across beauty and global markets, while Colgate-Palmolive leans...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
XRP trades near the $0.72 mark in early July 2026 as AI-driven forecasts weigh regulatory and macro factors. The pric...
Shark Tank’s Kevin O’Leary argues that the ability to execute trumps workplace location as firms accelerate return-to...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
In March 2026, traders are weighing CenterPoint Securities alternatives as costs diverge and platforms upgrade featur...
Barstool founder Dave Portnoy tells Fox Business he will hold Bitcoin to zero after buying near $100,000, underscorin...
Aave CEO Stani Kulechov unveiled a framework to speed up DAO decisions, following a governance dispute that saw BGD L...